Stockscreener 앱 받기
1.52
0.33%
0.005
시간 외 거래:
1.52
Lava Therapeutics Nv 주식(LVTX)의 최신 뉴스
Gilde healthcare sells LAVA Therapeutics (LVTX) shares for $718k By Investing.com - Investing.com UK
How LAVA Therapeutics N.V. stock valuations compare to rivalsFed Meeting & Real-Time Volume Analysis Alerts - newser.com
Price momentum metrics for LAVA Therapeutics N.V. explainedJuly 2025 Spike Watch & Low Risk High Win Rate Stock Picks - newser.com
What indicators show strength in LAVA Therapeutics N.V.Gap Down & Entry and Exit Point Strategies - newser.com
Can LAVA Therapeutics N.V. hit a new high this monthJuly 2025 Spike Watch & High Return Trade Opportunity Guides - newser.com
Will LAVA Therapeutics N.V. stock go up soonQuarterly Earnings Summary & Target Return Focused Stock Picks - newser.com
LAVA Therapeutics N.V. stock prediction for this weekDollar Strength & Weekly Stock Performance Updates - newser.com
LAVA Therapeutics N.V. Stock (LVTX) Opinions on Insider Sales and Acquisition Delays - Quiver Quantitative
Gilde Healthcare sells LAVA Therapeutics (LVTX) shares for $197,898 By Investing.com - Investing.com Canada
Gilde Healthcare sells LAVA Therapeutics (LVTX) shares for $197,898 - Investing.com
LAVA Therapeutics N.V. recovery potential after sell offPortfolio Return Report & Safe Entry Zone Identification - newser.com
Can LAVA Therapeutics N.V. rally from current levelsJuly 2025 Setups & High Yield Equity Trading Tips - newser.com
Is LAVA Therapeutics N.V. forming a reversal patternLayoff News & Expert Approved Momentum Trade Ideas - newser.com
Is LAVA Therapeutics N.V. (4PKB) stock overpriced at current multiplesJuly 2025 Momentum & Low Drawdown Momentum Ideas - newser.com
Why LAVA Therapeutics N.V. stock remains resilientTrade Signal Summary & High Win Rate Trade Tips - newser.com
Published on: 2025-10-05 06:23:52 - newser.com
Analyzing recovery setups for LAVA Therapeutics N.V. investorsJuly 2025 Analyst Calls & Free Fast Gain Swing Trade Alerts - newser.com
Measuring LAVA Therapeutics N.V.’s beta against major indicesQuarterly Trade Report & High Conviction Investment Ideas - newser.com
Will LAVA Therapeutics N.V. outperform the marketJuly 2025 Setups & Entry Point Confirmation Signals - newser.com
What candlestick patterns are forming on LAVA Therapeutics N.V.Weekly Trend Recap & Daily Oversold Bounce Ideas - newser.com
How LAVA Therapeutics N.V. stock performs in rate cut cyclesJuly 2025 Catalysts & Fast Gaining Stock Strategy Reports - newser.com
XOMA Royalty extends tender offer deadline for LAVA Therapeutics By Investing.com - Investing.com Australia
Shay Capital LLC Acquires Significant Stake in LAVA Therapeutics NV - GuruFocus
LAVA Therapeutics Extends Tender Offer Deadline - TipRanks
XOMA Royalty extends tender offer deadline for LAVA Therapeutics - Investing.com India
XOMA Royalty Corporation Extends Tender Offer for LAVA Therapeutics Shares Until October 17, 2025 - Quiver Quantitative
XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V. - GlobeNewswire
XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V. - Benzinga
75% CVR: XOMA Royalty Extends Tender Offer for LAVA, Extended to Oct. 17 - Stock Titan
What drives LAVA Therapeutics NV stock priceBollinger Bands Signals & High-Risk, High-Reward? We Find the Winners - earlytimes.in
LAVA Therapeutics Postpones EGM for XOMA Deal - MSN
LAVA Therapeutics to Move Extraordinary General Meeting to Early November 2025 - GlobeNewswire
LAVA Therapeutics Cancels Extraordinary General Meeting to Finalize XOMA Royalty Acquisition Details - Quiver Quantitative
Biotech Deal Update: LAVA Therapeutics Postpones XOMA Acquisition Vote to Address Cash Position - Stock Titan
2.96%
0.09%
자본화:
|
볼륨(24시간):